Reply to the Letter: "Low levels of transaminase and mortality risk in older people with special reference to sarcopenia"
Aging Clin Exp Res
.
2022 Jan;34(1):217.
doi: 10.1007/s40520-021-02023-6.
Epub 2021 Nov 16.
Authors
Paolo Gallo
1
,
Antonio De Vincentis
2
,
Stefania Bandinelli
3
,
Luigi Ferrucci
4
,
Antonio Picardi
1
,
Raffaele Antonelli Incalzi
5
,
Umberto Vespasiani-Gentilucci
1
Affiliations
1
Clinical Medicine and Hepatology Unit, Campus Bio-Medico University, Rome, Italy.
2
Internal Medicine Unit, Campus Bio-Medico University, Via Alvaro del Portillo, 200 00128, Rome, Italy. a.devincentis@unicampus.it.
3
Geriatric Unit, Azienda Sanitaria di Firenze Toscana, Firenze, Italy.
4
National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
5
Internal Medicine Unit, Campus Bio-Medico University, Via Alvaro del Portillo, 200 00128, Rome, Italy.
PMID:
34784018
DOI:
10.1007/s40520-021-02023-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Aged
Geriatric Assessment
Humans
Sarcopenia* / mortality
Transaminases
Substances
Transaminases